- How it Works
- Applications Overview
- Bioprocess Development
- Molecular Biology
September 30, 2015
Dow AgroSciences and Synthace Collaborate Using Synthace Platform
Written by: Synthace Team
Synthace and Dow AgroSciences LLC, a wholly-owned subsidiary of The Dow Chemical Company (NYSE: DOW), today announced they have entered into a research collaboration to optimize technology by accelerating the development of fermentation-based production of crop protection products.
The collaboration includes a multi-seat enterprise license giving Dow AgroSciences access to Synthace’s software and tools. As part of the agreement, Synthace’s advanced tools and software will be used to support the development of superior microbial production strains at Dow AgroSciences. This collaboration brings together expertise in natural products from both companies to enable new approaches for accelerated product development.
This collaboration supports the ability of Dow AgroSciences to use the power of nature in conjunction with fermentation technology, to produce and develop solutions for farmers. These types of products prevent pest infestation and control disease to increase crop yields. Applying automated strain engineering enables quicker development of new microbial production hosts in the lab which can expedite the development of fermentation processes for new products. Farmers win as new solutions can be brought to market more quickly. Dr. Tim Fell, Chief Executive Officer of Synthace, commented, “The Synthace platform links research, development, and biomanufacturing. We look forward to employing it with Dow AgroSciences to optimize tools and processes that enable them to continue to boost bottom-line performance.”
“It is important for Dow AgroSciences to bring new products to farmers faster and this collaboration on strain engineering will accelerate our ability to create novel microbial production strains,” said Dr. Nigel J. Mouncey, Bioengineering and Bioprocessing R&D Director, Dow AgroSciences. “Working with Synthace gives us the ability to achieve our goals more quickly in an expanded and automated manner via their innovative technologies.”
Synthace engineers biology for applications across health, food, energy, and manufacturing. Combining computation, biology, and automation the company rapidly develops robust, high-yielding bioprocesses to make bio-based products with strategic partners. Central to Synthace’s technology is the Synthace platform, which brings quality by design and design for manufacturing to biological research and development. Learn more at www.synthace.com.
About Dow AgroSciences
Dow AgroSciences discovers, develops, and brings to market crop protection and plant biotechnology solutions for the growing world. Based in Indianapolis, Indiana, USA, Dow AgroSciences is a wholly owned subsidiary of The Dow Chemical Company and had annual global sales of $7.3 billion in 2014. Learn more at www.dowagro.com. Follow Dow AgroSciences on Facebook, Twitter, LinkedIn, and Google+, or subscribe to our News Release RSS Feed.